Actelion Pharmaceuticals US, Inc. et al v. Lannett Company, Inc.

Docket(#7) WAIVER OF SERVICE returned executed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd.: For Lannett Company, Inc. waiver sent on 10/23/2024, answer due 12/23/2024. (Balick, Steven) (Entered: 10/24/2024)

DocketCase Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 10/23/2024)

DocketNo Summons Issued. (scs) (Entered: 10/18/2024)

Docket(#6) Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shinyaku Co., Ltd.. (scs) (Entered: 10/18/2024)

Docket(#5) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. (scs) (Entered: 10/18/2024)

Docket(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,122; 9,284,280. (scs) (Entered: 10/18/2024)

Docket(#3) Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/9/2027. (scs) (Entered: 10/18/2024)

Docket(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 10/18/2024)

Docket(#1) COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Lannett Company, Inc. ( Filing fee $ 405, receipt number ADEDC-4526668.) - filed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Shinyaku Co., Ltd.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(scs) (Entered: 10/18/2024)